FDAnews Drug Daily Bulletin
Pharmaceuticals

FDA Work Slows Due to Government Shutdown

Jan. 22, 2018
A A

Congress’s failure to pass a government funding bill last weekend means much — but not all — of FDA’s work will stop until an appropriations bill is passed.

The Department of Health and Human Services shutdown contingency plan states that many of its workers would be immediately furloughed, but some activities will continue. For-cause, whistleblower and safety signal inspections will continue as normal. However, routine establishment inspections are now on hold.

FDA personnel whose work is funded by outside user fees, such as PDUFA, would be able to keep working, but at a slower pace due to fewer employees. Anything that could directly impact public health will continue.

All requests for comments to FDA were referred to the Office of Management and Budget, which did not respond to requests for comment.

View today's stories